An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Catalent, Inc. to Present at June Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Catalent, the global leader in enabling biopharma and consumer health partners, announced its executive leadership team will present at two investor conferences. The presentations will take place on June 7, 2022 at 1:00 p.m. ET during the William Blair Annual Growth Stock Conference, and on June 8, 2022 at 8:00 a.m. ET at the Jefferies 2022 Healthcare Conference. Live webcasts will be available on their investor site and can be replayed post-event. Catalent, recognized for accelerating partner programs and product launches, generated $4 billion in revenue in 2021.
Positive
None.
Negative
None.
SOMERSET, N.J.--(BUSINESS WIRE)--
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership team will present at two upcoming investor conferences.
On June 7, 2022 at 1:00 p.m. ET, the Company will present at the William Blair Annual Growth Stock Conference. On June 8, 2022, at 8:00 a.m. ET, the Company will present at the Jefferies 2022 Healthcare Conference.
A live webcast of both presentations will be accessible at http://investor.catalent.com and will be available for replay following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is the industry’s preferred partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of nearly 7,000 products to over 1,000 customers annually. Catalent’s expert workforce exceeds 19,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit www.catalent.com.
What are the dates and times of Catalent's presentations at the investor conferences?
Catalent will present on June 7, 2022, at 1:00 p.m. ET at the William Blair Annual Growth Stock Conference and on June 8, 2022, at 8:00 a.m. ET at the Jefferies 2022 Healthcare Conference.
How can I access the webcasts of Catalent's investor presentations?
Live webcasts of Catalent's presentations will be available on their investor site at http://investor.catalent.com and can be replayed afterwards.
What is Catalent's revenue for the fiscal year 2021?
Catalent generated $4 billion in revenue in its 2021 fiscal year.
What services does Catalent provide in the biopharma sector?
Catalent enables biopharma, cell, gene, and consumer health partners to optimize product development, launch, and supply across various modalities.
How many products does Catalent launch each year?
Catalent helps launch over 150 new products annually.
